KROS - Keros Therapeutics to Present at Upcoming Healthcare Conferences | Benzinga
LEXINGTON, Mass., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. ("Keros") (NASDAQ:KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta ("TGF-ß") family of proteins, today announced that Keros' President and Chief Executive Officer Jasbir S. Seehra, Ph.D., will present at the following healthcare conferences:
Stifel 2023 Healthcare Conference
- Date and Time: Tuesday, November 14, 2023 at 2:25 p.m. Eastern time
- Link: A live audio webcast will be available at https://wsw.com/webcast/stifel83/kros/2121198
- Format: Corporate Presentation
Piper Sandler 35th ...